Cargando…
Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
BACKGROUND: To compare the reoperation rate in patients with vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR) with or without preoperative intravitreal bevacizumab (IVB). METHODS: In this retrospective study, 280 patients (362 eyes) with diabetic VH were divided into a...
Autores principales: | Hu, Xuting, Pan, Qintuo, Zheng, Jingwei, Song, Zongming, Zhang, Zongduan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743107/ https://www.ncbi.nlm.nih.gov/pubmed/31519158 http://dx.doi.org/10.1186/s12886-019-1179-x |
Ejemplares similares
-
Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013) -
Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab a comparative overview
por: Faisal, Syed Muhammad, et al.
Publicado: (2018) -
Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
por: Joob, Beuy, et al.
Publicado: (2017) -
The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
por: Alagöz, Cengiz, et al.
Publicado: (2016) -
Treatment of Bacillus cereus endophthalmitis with endoscopy-assisted vitrectomy
por: Pan, Qintuo, et al.
Publicado: (2017)